Remy Luthringer - Oct 4, 2023 Form 4 Insider Report for Minerva Neurosciences, Inc. (NERV)

Role
CEO, Director
Signature
/s/ Ryan Sansom, Attorney-in-Fact
Stock symbol
NERV
Transactions as of
Oct 4, 2023
Transactions value $
$0
Form type
4
Date filed
10/5/2023, 04:34 PM
Previous filing
May 2, 2023
Next filing
Dec 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NERV Employee Stock Option (right to buy) Award $0 +100K $0.00 100K Oct 4, 2023 Common Stock 100K $6.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on October 4, 2024 and then in equal quarterly installments over 3 years thereafter.